Stephen Cohen, MD
Physical Medicine & Rehabilitation · Camden, NJNPI 1417968355
Payments from drug & device makers
Across 19 payments — averaging $79.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$903
- Fidia Pharma USA Inc.$373
- Koya Medical, Inc.$51
- Johnson & Johnson$36
- Globus Medical$28
- Merz Pharmaceuticals, LLC$24
- plus $103 from 6 others
What the payments were for
- Speaking & faculty fees$20013%
- Travel & lodging$71447%
- Food & beverage$60540%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 5 | $903 |
| Fidia Pharma USA Inc. | 4 | $373 |
| Koya Medical, Inc. | 1 | $51 |
| Johnson & Johnson | 1 | $36 |
| Globus Medical | 1 | $28 |
| Merz Pharmaceuticals, LLC | 1 | $24 |
| Philips North America LLC | 1 | $20 |
| AbbVie | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Argenx US, Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,519 in reported general payments places this provider in the 80th percentile of 434 physical medicine & rehabilitation providers in New Jersey.
See all physical medicine & rehabilitation providers in New Jersey →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nucynta ErTapentadol Hcl | 14 | $16,326 |
| OxycontinOxycodone Hcl | 27 | $15,371 |
| LyricaPregabalin | 11 | $6,053 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 77 | $2,090 |
| Oxycodone Hcl | 82 | $1,305 |
| Morphine Sulfate | 25 | $899 |
| Baclofen | 19 | $480 |
| Morphine Sulfate ErMorphine Sulfate | 25 | $471 |
| EndocetOxycodone Hcl/Acetaminophen | 11 | $424 |
| Pregabalin | 22 | $336 |
| Duloxetine Hcl | 31 | $325 |
| Gabapentin | 24 | $282 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Camden
- Anand PooleriCamden$13K
- Harla O'DonnellCamden$6K
- Scott WoskaTinton Falls$2M
- Brian KimToms River$459K
- Steven EscaldiEdison$74K
- Yekyung KongWest Orange$61K
- Michael VerdeToms River$54K
- Joseph IbrahimBayonne$52K
- Steven KirshblumWest Orange$51K
- Brian GreenwaldEdison$39K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.